EVIDENCE
Evidence matters most when it is specific.
We treat evidence as a disciplined architecture, not as a pile of claims waiting to be reused.
Background, current product, and what bridges them.
CleverSkin has technical, biological/toxicological and clinical-use records. Our current programme treats those materials as scientific background and potential bridging evidence, not as automatic regulatory acceptance for CleverSkin24.
Technical evidence
Material behaviour, handling characteristics, product engineering and packaging development inform the current programme.
Biological / toxicological evidence
Historical data can guide risk assessment and testing strategy, but the current product still needs current-product closure against the relevant route.
Clinical-use records
Prior use experience can help shape practical questions, user needs and bridging logic. It is not treated as an automatic substitute for the evidence required for CleverSkin24.
Current principle
Useful history is valuable. Automatic carry-over is not. We separate background knowledge, bridgeable evidence and current-product evidence so that each claim sits on the right foundation.
The current evidence programme
- Chemistry and materials characterisation.
- Biological evaluation and toxicological assessment.
- Performance and packaging verification.
- Usability and user-sequence validation.
- Route-specific regulatory evidence closure.